STAGE III GASTRIC CANCER AJCC V7
Clinical trials for STAGE III GASTRIC CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III GASTRIC CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III GASTRIC CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy trial aims to boost stomach cancer survival
Disease control OngoingThis study is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation improves outcomes for people with operable stomach cancer. It focuses on two specific types: cancers with mismatch repair deficiency or Epstein-Barr virus positivity. …
Matched conditions: STAGE III GASTRIC CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New pill aims to supercharge radiation against tough cancers
Disease control OngoingThis early-stage study is testing a new oral drug called ropidoxuridine (IPdR) in patients with advanced gastrointestinal cancers that have spread. The main goal is to find the safest dose of the drug when taken daily alongside standard radiation therapy. Researchers hope the dru…
Matched conditions: STAGE III GASTRIC CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC